Catalyst Pharmaceuticals (CPRX) Work In Process: 2023-2025
Historic Work In Process for Catalyst Pharmaceuticals (CPRX) over the last 2 years, with Sep 2025 value amounting to $4.6 million.
- Catalyst Pharmaceuticals' Work In Process rose 20.18% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 20.18%. This contributed to the annual value of $3.4 million for FY2024, which is 24.67% down from last year.
- According to the latest figures from Q3 2025, Catalyst Pharmaceuticals' Work In Process is $4.6 million, which was down 13.98% from $5.3 million recorded in Q2 2025.
- In the past 5 years, Catalyst Pharmaceuticals' Work In Process ranged from a high of $5.3 million in Q2 2025 and a low of $3.4 million during Q4 2024.
- Its 3-year average for Work In Process is $4.3 million, with a median of $4.2 million in 2025.
- As far as peak fluctuations go, Catalyst Pharmaceuticals' Work In Process declined by 24.67% in 2024, and later spiked by 32.89% in 2025.
- Quarterly analysis of 3 years shows Catalyst Pharmaceuticals' Work In Process stood at $4.6 million in 2023, then fell by 24.67% to $3.4 million in 2024, then climbed by 20.18% to $4.6 million in 2025.
- Its last three reported values are $4.6 million in Q3 2025, $5.3 million for Q2 2025, and $4.2 million during Q1 2025.